… The evidence from this review suggests small but significant efficacy of the approved
nirmatrelvir/ritonavir regimen in decreasing COVID-19 hospitalization and its effectiveness (from …

… With the identification of the psychiatric medication contraindications with nirmatrelvir/ritonavir,
our facility was able to develop guidance on nirmatrelvir/ritonavir and clozapine that was …

… We found two studies with 2510 participants that investigated nirmatrelvir/ritonavir compared
to placebo or standard of care for the treatment of COVID‐19 in people without previous …

… nirmatrelvir-ritonavir according to the EUA. Patients who did not pick up their prescription for
nirmatrelvir-ritonavir … Nirmatrelvir-ritonavir effectiveness was evaluated as the incidence of …

… Objectives The aim of this analysis was to describe nirmatrelvir/ritonavir real-world effectiveness
in preventing hospitalization among high-risk US COVID-19 patients during SARS-CoV-…

… Residents of long-term care homes and patients that received nirmtrelvir-ritonavir while
admitted as inpatients were excluded as these individuals could not be followed by the CAC. We …

… nirmatrelvir-ritonavir, perhaps because of the multiple drug-drug interactions associated with
the latter. When nirmatrelvir-ritonavir … than the nirmatrelvir-ritonavir and untreated cohorts. …

… 0·056 for nirmatrelvir plus ritonavir), whereas the effect on mortality was not significant for
molnupiravir, and not evaluable for nirmatrelvir plus ritonavir … and nirmatrelvir plus ritonavir was …

… since the introduction of nirmatrelvir/ritonavir to the market … the therapeutic efficacy of
nirmatrelvir/ritonavir in elderly patients … Blood drug concentrations of nirmatrelvir and ritonavir were …

… , and first-grade obesity, he started nirmatrelvir/ritonavir treatment the same day, which was
… and previous lung cancer, he started nirmatrelvir/ritonavir treatment on 17 March, which was …